Takeda Pharmaceutical Company Limited

4502

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-07-30FY2027 Q1

Revenue

4.62T JPY

YoY +3.1%

Operating Income

2014.2100M JPY

YoY +9.1%

Net Income

-1634.4100M JPY

YoY -219.4%

EPS

71.7JPY

YoY -9.8%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

4.6兆円

3.4兆円

2.2兆円

1兆円

-1523.9億円

Rev: 3.6兆円Op: 4608.4億円NI: 2300.6億円

Rev: 4兆円Op: 4905.1億円NI: 3170.2億円

Rev: 4.3兆円Op: 2140.8億円NI: 1440.7億円

Rev: 4.6兆円Op: 3425.9億円NI: 1079.3億円

Rev: 4.5兆円Op: 62.2億円NI: -1523.9億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income68.2%

Revenue Progress1.2T

Revenue Forecast4.6T

Net Income Progress113200M

Net Income Forecast166000M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan